← Back to Clinical Trials
Recruiting NCT07179172

NCT07179172 Neurobiological Investigations of Mindfulness, Depression and Sleep Disturbances in Medical Staffs and Community Elders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07179172
Status Recruiting
Phase
Sponsor Taipei Medical University Shuang Ho Hospital
Condition Sleep Disturbances
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-06-14
Primary Completion 2025-11-08

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
Mindfulness-Based Stress Reduction (MBSR) 8-Week Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-06-14 with a primary completion date of 2025-11-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The research team proposes a multi-year study with the first year focusing on the developmental phase. In this initial phase, we aim to recruit 40 participants (including healthcare staff and older adults) from Shuang-Ho Hospital and the surrounding community to undergo two mindfulness intervention sessions, each lasting four months. We anticipate that these interventions will prevent and alleviate stress and depressive symptoms while enhancing self-awareness and psychological health.

Eligibility Criteria

Inclusion Criteria: 1. Hospital staff aged 20-65 years, or elderly individuals aged 55-90 years. 2. Individuals willing to participate in the entire mindfulness course and comply with study enrollment procedures.- Exclusion Criteria: 1. History of major neurological disorders (e.g., epilepsy, Parkinson's disease, stroke). 2. History of major psychiatric disorders (e.g., schizophrenia, bipolar disorder). 3. Use of medications that may affect sleep, other than illegal substances or sleeping pills. 4. Individuals with metal implants. 5. Individuals with claustrophobia. 6. Pregnant women. 7. History of alcohol or substance addiction.

Contact & Investigator

Central Contact

Jiunn-Kae Wang, MD, MSc

✉ 14073@s.tmu.edu.tw

📞 +886970749758

Frequently Asked Questions

Who can join the NCT07179172 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Sleep Disturbances. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07179172 currently recruiting?

Yes, NCT07179172 is actively recruiting participants. Contact the research team at 14073@s.tmu.edu.tw for enrollment information.

Where is the NCT07179172 trial being conducted?

This trial is being conducted at New Taipei City, Taiwan.

Who is sponsoring the NCT07179172 clinical trial?

NCT07179172 is sponsored by Taipei Medical University Shuang Ho Hospital. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology